Gabelli & Co Investment Advisers’s Nexvet Biopharma plc Ordinary Shares NVET Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio NVET Stock Details NVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-71,100	Closed	-$476K	–	192
2017 Q2	$476K	Buy	+71,100	New	+$447K	0.05%	119

Gabelli & Co Investment Advisers's NVET Position: Q3 2017 in Review

Gabelli & Co Investment Advisers sold out of Nexvet Biopharma plc Ordinary Shares (NVET) in Q3 2017, closing a stake of 71,100 shares — an estimated $476K sold.

Gabelli & Co Investment Advisers first reported a position in NVET in Q2 2017 and held it in 1 quarter. The position peaked at $476K in Q2 2017. 0 funds tracked by Wall St. Rank hold NVET as of Q3 2017.

Gabelli & Co Investment Advisers reported no remaining Nexvet Biopharma plc Ordinary Shares position as of Q3 2017 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 71,100 Nexvet Biopharma plc Ordinary Shares shares in Q3 2017, an estimated $476K.
Gabelli & Co Investment Advisers first reported a position in Nexvet Biopharma plc Ordinary Shares in Q2 2017 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Nexvet Biopharma plc Ordinary Shares position peaked at $476K in Q2 2017.
0 funds tracked by Wall St. Rank held Nexvet Biopharma plc Ordinary Shares as of Q3 2017.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2017, filed 1 Nov 2017.